NEW YORK, May 28, 2013  /PRNewswire/ --

CapLease, Inc.  

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of CapLease, Inc. ("CapLease") (LSE) to American Realty Capital Properties, Inc. in a transaction valued at approximately $2.2 billion or $8.50 per share for each outstanding share of CapLease common stock, and each share of Series A, Series B and Series C preferred stock of CapLease will be converted into the right to receive the sum of $25.00 in cash plus an amount equal to any accrued and unpaid dividends up to but excluding the closing date of the merger.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the CapLease's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Lender Processing Services, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Lender Processing Services, Inc. (LPS) to Fidelity National Financial, Inc. in a transaction valued at approximately $2.9 billion or $33.25 per share in cash.

Lifshitz Law Firm's investigation is focused on whether the proposed deal provides adequate value to the Company's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Omthera Pharmaceuticals, Inc.

Lifshitz Law Firm announces an investigation into possible breaches of fiduciary duty in connection with the proposed sale of Omthera Pharmaceuticals, Inc. ("Omthera") (OMTH) to AstraZeneca in a cash transaction valued at approximately $323 million or $12.70 per share.

Lifshitz Law Firm's investigation is focused on whether the proposed transaction provides adequate value to the Omthera's shareholders.

For more information about our investigation, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Vitamin Shoppe, Inc.

Lifshitz Law Firm announces that a class action suit was filed in the United States District Court for the District of New Jersey, alleging that Vitamin Shoppe, Inc. ("Vitamin Shoppe") (VSI) issued false and misleading statements to investors between May 8, 2012 and February 25, 2013, inclusive (the "Class Period") by failing to adequately disclose (i) Vitamin Shoppe's business was negatively impacted by competition from on-line retailers which were significantly reducing prices on popular supplements; (ii) GNC's new discount program was negatively impacting Vitamin Shoppe's sales growth; and (iii) Vitamin Shoppe was experiencing declining same-store sales trends.  The firm is investigating legal claims against the officers and Board of Directors of Vitamin Shoppe.

For more information, please contact Joshua M. Lifshitz, Esq. by telephone at (212) 213-6222 Ext. 18 or by sending an e-mail including your contact information to: info@jlclasslaw.com.

Lifshitz Law Firm is a New York based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions.  For more information about the firm, please visit our website at www.jlclasslaw.com.

ATTORNEY ADVERTISING. © 2013 Lifshitz Law Firm.  The law firm responsible for this advertisement is Lifshitz Law Firm, 18 East 41st Street, New York, New York 10017, (212) 213-6222.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz Law Firm
Phone:   212-213-6222
Email: info@jlclasslaw.com

SOURCE Lifshitz Law Firm

Copyright 2013 PR Newswire

OMTHERA PHARMACEUTICALS, INC. (NASDAQ:OMTH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos OMTHERA PHARMACEUTICALS, INC..
OMTHERA PHARMACEUTICALS, INC. (NASDAQ:OMTH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos OMTHERA PHARMACEUTICALS, INC..